SAVE Act

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $1,090,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Ban Surprise Billing Act (H.R. 5800) Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826) Dependent Income Exclusion Act of 2019 (H.R.4417/S.2497) Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R.1143) ENROLL Act of 2019 (H.R.1386/S.1905) Family Coverage Act (S.1935) HEARTS Act of 2020 (H.R. 6166) The Heroes Act (H.R. 6800) Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R.4768) Lower Health Care Costs Act (S.1895) Marketing & Outreach Restoration to Empower Health Education Act (MORE) (H.R.987) No Surprises Act (H.R.3630) The Patient Protection and Affordable Care Enhancement Act (H.R. 1425) Personal Health Investment Today Act (PHIT) (S.680/H.R.1679) Physical Activity Recommendations (PAR) for Americans Act (S.1608/H.R.2891) Pre-existing Conditions Protection Act of 2019 (H.R.692) Protect Act (S.1125) Protecting Access to Post COVID-19 Telehealth Act of 2020 (H.R. 7663) Protecting Americans with Pre-existing Conditions Act of 2019 (H.R.986) Public Health Funding Restoration Act (S.1944/H.R.3447) Quit Because of COVID-19 Act (H.R. 7286) A Resolution Supporting the Designation of April 2019 as "National Donate Life Month"(H.Res 315/S.Res 162) South Asian Heart Health Awareness and Research Act of 2019 (H.R.3131) State Allowance for a Variety of Exchanges Act (SAVE Act) (H.R.1385) States Achieve Medicaid Expansion (S.585) State Health Care Premium Reduction Act (H.R.1425) Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (S.1531) Sustaining Outpatient Services Act (H.R. 4838/S.4151) Implementation of: Menu Labeling Physical Activity Guidelines Recommendations Prevention and Public Health Fund (PL 111-148, Sec 4002)

Client expense: $170,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; Issues related to telehealth; Issues related to changing federal poverty line calculation; Issues related to COVID-19 Response;; H.R.986 Protecting Americans with Preexisting Conditions Act of 2019 H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1010 To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.1385 SAVE Act H.R.1386 ENROLL Act of 2019 H.R.1425 State Health Care Premium Reduction Act H.R.1499 Protecting Consumer Access to Generic Drugs Act of 2019 H.R.1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 H.R.2508 Better Respiration through Expanding Access to Tele-Health Act;H.R.2862 VACCINES Act of 2019; H.R.3630 No Surprises Act H.R.4622 Family Asthma Act S.466 Protecting Americans with Pre-existing Conditions Act of 2019 S.946 Henrietta Lacks Enhancing Cancer Research Act of 2019 S.1125 Protect Act S.1895 Lower Health Care Costs Act S.1944 Public Health Funding Restoration Act. HR 3 Elijah E. Cummings Lower Drug Costs Now Act; H.R.4716 I CAN Act; HR 5230 Elijah E. Cummings Family Asthma Act; HR 6201 - Families First Coronavirus Act; HR 6704 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; HR 748 - CARES Act; S. 3548 - CARES Act; S. 1531 - Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 6408 -- To extend the charitable deduction to all taxpayers regardless of whether a taxpayer itemizes deductions in order to encourage and increase charitable giving, and to provide for loans and loan guarantees to certain public charities; HR 7610 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021; HR 7667 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021; HR 7617 Department of Defense Appropriations Act, 2021; HR 7612 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2021; HR 2468 School-Based Allergies and Asthma Management Program Act; HR 7614 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021; HR 7609 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021; HR 7616 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2021; HR 7608 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2021; H.R.5076 Protecting Seniors Through Immunization Act of 2019; H.R.6561 Improving Social Determinants of Health Act of 2020; HR 6800 HEROES Act; H.R.6935 Protecting the Health of America's Older Adults During COVID-19 and Beyond Act; HR 7286 Quit Because of COVID-19 Act; S. 4775 Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act; S. 4321 The Continuing Small Business Recovery and Paycheck Protection Program Act; S. 4318 The American Workers, Families, and Employers Assistance Act; S. 4317 SAFE TO WORK Act; S. 4322 The Safely Back to School and Back to Work Act; S. 4320 Coronavirus Response Additional Supplemental Appropriations Act, 2020; ;H.R.8061 Community Immunity During COVID-19 Act of 2020;H.R.8406 The Heroes Act; H.R.925 The Heroes Act; S.4557 COVER Act; S.4740 A bill to support public health infrastructure; H.RES.957 Expressing support for the designation of May as "National Asthma and Allergy Awareness Month"; H.R.7011 Pandemic Risk Insurance Act of 2020; H.R.8261 Presumptive Benefits for War Fighters Exposed to Burn Pits and Other Toxins Act of 2020; S.4572 Presumptive Benefits for War Fighters Exposed to Burn Pits and Other Toxins Act of 2020; S.4355 Katherine's Lung Cancer Early Detection and Survival Act of 2020; H.RES.1192 Expressing support for the goals of November National Lung Cancer Awareness Month and for the early detection of lung cancer; H.R.8158 To amend title XVIII of the Social Security Act to waive budget neutrality for oxygen under the Medicare program, and for other purposes.;H.R.7481 RESTART Act; S.4737 A bill to amend the Public Health Service Act to direct the Secretary of Health and Human Services to make grants to covered health departments to increase the rate of recommended immunizations, and for other purposes;

Client expense: $40,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $1,600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Ban Surprise Billing Act (H.R. 5800) Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826) Dependent Income Exclusion Act of 2019 (H.R.4417/S.2497) Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R.1143) ENROLL Act of 2019 (H.R.1386/S.1905) Family Coverage Act (S.1935) HEARTS Act of 2020 (H.R. 6166) The Heroes Act (H.R. 6800) Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R.4768) Lower Health Care Costs Act (S.1895) Marketing & Outreach Restoration to Empower Health Education Act (MORE) (H.R.987) No Surprises Act (H.R.3630) The Patient Protection and Affordable Care Enhancement Act (H.R. 1425) Personal Health Investment Today Act (PHIT) (S.680/H.R.1679) Physical Activity Recommendations (PAR) for Americans Act (S.1608/H.R.2891) Pre-existing Conditions Protection Act of 2019 (H.R.692) Protect Act (S.1125) Protecting Americans with Pre-existing Conditions Act of 2019 (H.R.986) Public Health Funding Restoration Act (S.1944/H.R.3447) Quit Because of COVID-19 Act (H.R. 7286) A Resolution Supporting the Designation of April 2019 as "National Donate Life Month"(H.Res 315/S.Res 162) South Asian Heart Health Awareness and Research Act of 2019 (H.R.3131) State Allowance for a Variety of Exchanges Act (SAVE Act) (H.R.1385) States Achieve Medicaid Expansion (S.585) State Health Care Premium Reduction Act (H.R.1425) Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (S.1531) Implementation of: Menu Labeling Physical Activity Guidelines Recommendations Prevention and Public Health Fund (PL 111-148, Sec 4002)

Client expense: $582,750 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; Issues related to telehealth; Issues related to changing federal poverty line calculation; Issues related to COVID-19 Response; H.R.965 CREATES Act of 2019; H.R.986 Protecting Americans with Preexisting Conditions Act of 2019 H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1010 To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.1385 SAVE Act H.R.1386 ENROLL Act of 2019 H.R.1425 State Health Care Premium Reduction Act H.R.1499 Protecting Consumer Access to Generic Drugs Act of 2019 H.R.1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 H.R.2508 Better Respiration through Expanding Access to Tele-Health Act;H.R.2862 VACCINES Act of 2019; H.R.3630 No Surprises Act H.R.4622 Family Asthma Act S.340 CREATES Act of 2019 S.466 Protecting Americans with Pre-existing Conditions Act of 2019 S.946 Henrietta Lacks Enhancing Cancer Research Act of 2019 S.1125 Protect Act S.1895 Lower Health Care Costs Act S.1944 Public Health Funding Restoration Act. HR 3 Elijah E. Cummings Lower Drug Costs Now Act; H.R.4716 I CAN Act; HR 5230 Elijah E. Cummings Family Asthma Act; HR 6201 - Families First Coronavirus Act; HR 6704 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; HR 748 - CARES Act; S. 3548 - CARES Act; S. 1531 - Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 6408 -- To extend the charitable deduction to all taxpayers regardless of whether a taxpayer itemizes deductions in order to encourage and increase charitable giving, and to provide for loans and loan guarantees to certain public charities; HR 7610 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021; HR 7667 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2021; HR 7617 Department of Defense Appropriations Act, 2021; HR 7612 Department of the Interior, Environment, and Related Agencies Appropriations Act, 2021; HR 2468 School-Based Allergies and Asthma Management Program Act; HR 7614 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021; HR 7609 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2021; HR 7616 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2021; HR 7608 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2021; H.R.5076 Protecting Seniors Through Immunization Act of 2019; H.R.6561 Improving Social Determinants of Health Act of 2020; HR 6800 HEROES Act; H.R.6935 Protecting the Health of America's Older Adults During COVID-19 and Beyond Act; HR 7286 Quit Because of COVID-19 Act;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, regarding all bio-pharmaceutical related provisions

Client expense: $2,160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Ban Surprise Billing Act (H.R. 5800) Consumer Protections Against Surprise Medical Bills Act of 2020 (H.R. 5826) Dependent Income Exclusion Act of 2019 (H.R.4417/S.2497) Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R.1143) ENROLL Act of 2019 (H.R.1386/S.1905) Family Coverage Act (S.1935) HEARTS Act of 2020 (H.R. 6166) Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R.4768) Lower Health Care Costs Act (S.1895) Marketing & Outreach Restoration to Empower Health Education Act (MORE) (H.R.987) No Surprises Act (H.R.3630) Personal Health Investment Today Act (PHIT) (S.680/H.R.1679) Physical Activity Recommendations (PAR) for Americans Act (S.1608/H.R.2891) Pre-existing Conditions Protection Act of 2019 (H.R.692) Protect Act (S.1125) Protecting Americans with Pre-existing Conditions Act of 2019 (H.R.986) Public Health Funding Restoration Act (S.1944/H.R.3447) A Resolution Supporting the Designation of April 2019 as "National Donate Life Month"(H.Res 315/S.Res 162) South Asian Heart Health Awareness and Research Act of 2019 (H.R.3131) State Allowance for a Variety of Exchanges Act (SAVE Act) (H.R.1385) States Achieve Medicaid Expansion (S.585) State Health Care Premium Reduction Act (H.R.1425) Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (S.1531) To provide that the rule "STLDI" shall have no force or effect (H.R.1010) 911 Saves Act (H.R.1629) Implementation of: Menu Labeling Physical Activity Guidelines Recommendations Prevention and Public Health Fund (PL 111-148, Sec 4002) Resolution to: Designating February 2020 as "American Heart Month" and February 7, 2020, as "National Wear Red Day" (S.Res.513) Recognizing the rise of cardiovascular disease as the world's leading cause of preventable death and disability and as a global public health crisis and supporting the recognition of February 2020 as "American Heart Month" (H.Res. 860)

Client expense: $250,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; Issues related to telehealth; Issues related to changing federal poverty line calculation; Issues related to COVID-19 Response; Issues related to FY21 appropriations including Labor, Health and Human Services, Education and Related Agencies; H.R.965 CREATES Act of 2019; H.R.986 Protecting Americans with Preexisting Conditions Act of 2019 H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1010 To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.1385 SAVE Act H.R.1386 ENROLL Act of 2019 H.R.1425 State Health Care Premium Reduction Act H.R.1499 Protecting Consumer Access to Generic Drugs Act of 2019 H.R.1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 H.R.2508 Better Respiration through Expanding Access to Tele-Health Act;H.R.2862 VACCINES Act of 2019; H.R.3630 No Surprises Act H.R.4622 Family Asthma Act S.340 CREATES Act of 2019 S.466 Protecting Americans with Pre-existing Conditions Act of 2019 S.946 Henrietta Lacks Enhancing Cancer Research Act of 2019 S.1125 Protect Act S.1895 Lower Health Care Costs Act S.1944 Public Health Funding Restoration Act. HR 3 Elijah E. Cummings Lower Drug Costs Now Act; H.R.4716 I CAN Act; HR 5230 Elijah E. Cummings Family Asthma Act; HR 6201 - Families First Coronavirus Act; HR 6704 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; HR 748 - CARES Act; S. 3548 - CARES Act; S. 1531 - Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 6408 -- To extend the charitable deduction to all taxpayers regardless of whether a taxpayer itemizes deductions in order to encourage and increase charitable giving, and to provide for loans and loan guarantees to certain public charities;

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Postal Regulatory Commission, SENATE, Treasury, Dept of, White House Office

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions H.R 748/S. 3548, Coronavirus Aid, Relief and Economic Security Act (CARES Act), regarding all bio-pharmaceutical related provisions

Client expense: $540,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

H.R. 1781 - Payment Commission Data Act of 2019: Issues regarding providing the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to drug pricing and rebate data. H.R. 938 - Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019: Issues regarding discouraging parking of 180-day exclusivity by a first generic applicant that is blocking the approval of other generics. H.R. 1520 - Purple Book Continuity Act of 2019: Issues regarding codifying publication of the patents of approved biological products in the Purple Book in a similar format and with similar requirements to the Orange Book; Publication and regular updating of the Purple Book electronically on the FDAs website. H.R. 1503 - Orange Book Transparency Act of 2019: Issues regarding ensuring that the Orange Book is accurate and up-to-date, by requiring manufacturers to share complete and timely information with FDA, as well as ensuring that patents listed in the Orange Book are relevant to the approved drug product. H.R. 1499 - Protecting Consumer Access to Generic Drugs Act of 2019: Issues regarding brand-name and generic drug manufacturers entering into agreements in which the brand-name drug manufacturer pays the generic manufacturer to keep a generic equivalent off the market. H.R. 965, S. 340 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019: Issues regarding processes by which generic manufacturers can obtain sufficient quantities of brand drug samples for testing. H.R. 1385 - State Allowance for a Variety of Exchanges (SAVE) Act: Issues regarding federal funds to establish state-based Marketplaces. H.R. 1386 - Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act: Issues regarding funding for Federally-Facilitated Marketplace navigator program; requirements for navigator entities in each state; Health and Human Services ensuring that navigator grants are awarded to entities with demonstrated capacity to carry out the duties specified in the Affordable Care Act. H.R. 987 - Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019: Issues related to restoring outreach and enrollment funding to assist consumers in signing up for health care. H.R. 1010 - Issues regarding Short-Term, Limited Duration Insurance. H.R. 986 - Protecting Americans with Preexisting Conditions Act of 2019: Issues regarding rescinding Section 1332 guidance of the ACA promulgated in October 2018. H.R. 1425 - State Health Care Premium Reduction Act: Issues regarding state reinsurance program and providing financial assistance to reduce out-of-pocket costs. H.R. 820 - Public Health Service Act: Issues regarding National Institutes of Health support to collect the medical specimens and information of children with selected cancers that have the least effective treatments. 657 - Drug Price Transparency (DPT) Act: Issues relating to drug and price transparency. S. 80, S. 172 - Issues regarding repeal and delay of the health insurer fee. Issues regarding surprise billing, including benchmark payments and arbitration models.

Client expense: $1,590,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1781 - Payment Commission Data Act of 2019: Issues regarding providing the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to drug pricing and rebate data. H.R. 938 - Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019: Issues regarding discouraging parking of 180-day exclusivity by a first generic applicant that is blocking the approval of other generics. H.R. 1520 - Purple Book Continuity Act of 2019: Issues regarding codifying publication of the patents of approved biological products in the Purple Book in a similar format and with similar requirements to the Orange Book; Publication and regular updating of the Purple Book electronically on the FDAs website. H.R. 1503 - Orange Book Transparency Act of 2019: Issues regarding ensuring that the Orange Book is accurate and up-to-date, by requiring manufacturers to share complete and timely information with FDA, as well as ensuring that patents listed in the Orange Book are relevant to the approved drug product. H.R. 1499 - Protecting Consumer Access to Generic Drugs Act of 2019: Issues regarding brand-name and generic drug manufacturers entering into agreements in which the brand-name drug manufacturer pays the generic manufacturer to keep a generic equivalent off the market. H.R. 965, S. 340 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019: Issues regarding processes by which generic manufacturers can obtain sufficient quantities of brand drug samples for testing. H.R. 1385 - State Allowance for a Variety of Exchanges (SAVE) Act: Issues regarding federal funds to establish state-based Marketplaces. H.R. 1386 - Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act: Issues regarding funding for Federally-Facilitated Marketplace navigator program; requirements for navigator entities in each state; Health and Human Services ensuring that navigator grants are awarded to entities with demonstrated capacity to carry out the duties specified in the Affordable Care Act. H.R. 987 - Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019: Issues related to restoring outreach and enrollment funding to assist consumers in signing up for health care. H.R. 1010 - Issues regarding Short-Term, Limited Duration Insurance. H.R. 986 - Protecting Americans with Preexisting Conditions Act of 2019: Issues regarding rescinding Section 1332 guidance of the ACA promulgated in October 2018. H.R. 1425 - State Health Care Premium Reduction Act: Issues regarding state reinsurance program and providing financial assistance to reduce out-of-pocket costs. H.R. 820 - Public Health Service Act: Issues regarding National Institutes of Health support to collect the medical specimens and information of children with selected cancers that have the least effective treatments. H.R. 2069 - The SPIKE Act, H.R. 2113 - STAR Act, H.R. 2115 - Public Disclosure of Drug Discounts Act, H.R. 2296 - FAIR Drug Pricing Act, H.R. 2376 - Prescription Pricing for the People Act, H.R, 2757 - Creating Lower Cost Alternatives for Your Prescription Drugs Act, S. 657 - Drug Price Transparency (DPT) Act: Issues relating to drug and price transparency. H.R. 3253 - Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019: Regarding all provisions. S. 1895 - The Lower Health Care Costs Act: Regarding all provisions. S. 80, S. 172 - Issues regarding repeal and delay of the health insurer fee. Issues pertaining to surprise billing, including benchmark payments and arbitration models.

Client expense: $1,710,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1781 - Payment Commission Data Act of 2019: Issues regarding providing the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to drug pricing and rebate data. H.R. 938 - Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019: Issues regarding discouraging parking of 180-day exclusivity by a first generic applicant that is blocking the approval of other generics. H.R. 1520 - Purple Book Continuity Act of 2019: Issues regarding codifying publication of the patents of approved biological products in the Purple Book in a similar format and with similar requirements to the Orange Book; Publication and regular updating of the Purple Book electronically on the FDAs website. H.R. 1503 - Orange Book Transparency Act of 2019: Issues regarding ensuring that the Orange Book is accurate and up-to-date, by requiring manufacturers to share complete and timely information with FDA, as well as ensuring that patents listed in the Orange Book are relevant to the approved drug product. H.R. 1499 - Protecting Consumer Access to Generic Drugs Act of 2019: Issues regarding brand-name and generic drug manufacturers entering into agreements in which the brand-name drug manufacturer pays the generic manufacturer to keep a generic equivalent off the market. H.R. 965, S. 340 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019: Issues regarding processes by which generic manufacturers can obtain sufficient quantities of brand drug samples for testing. H.R. 1385 - State Allowance for a Variety of Exchanges (SAVE) Act: Issues regarding federal funds to establish state-based Marketplaces. H.R. 1386 - Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act: Issues regarding funding for Federally-Facilitated Marketplace navigator program; requirements for navigator entities in each state; Health and Human Services ensuring that navigator grants are awarded to entities with demonstrated capacity to carry out the duties specified in the Affordable Care Act. H.R. 987 - Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019: Issues related to restoring outreach and enrollment funding to assist consumers in signing up for health care. H.R. 1010 - Issues regarding Short-Term, Limited Duration Insurance. H.R. 986 - Protecting Americans with Preexisting Conditions Act of 2019: Issues regarding rescinding Section 1332 guidance of the ACA promulgated in October 2018. H.R. 1425 - State Health Care Premium Reduction Act: Issues regarding state reinsurance program and providing financial assistance to reduce out-of-pocket costs. H.R. 820 - Public Health Service Act: Issues regarding National Institutes of Health support to collect the medical specimens and information of children with selected cancers that have the least effective treatments. H.R. 2069 - The SPIKE Act, H.R. 2113 - STAR Act, H.R. 2115 - Public Disclosure of Drug Discounts Act, H.R. 2296 - FAIR Drug Pricing Act, H.R. 2376 - Prescription Pricing for the People Act, H.R, 2757 - Creating Lower Cost Alternatives for Your Prescription Drugs Act, S. 657 - Drug Price Transparency (DPT) Act: Issues relating to drug and price transparency. H.R. 3253 - Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019: Regarding all provisions. S. 1895 - The Lower Health Care Costs Act: Regarding all provisions. S. 80, S. 172 - Issues regarding repeal and delay of the health insurer fee. Issues pertaining to surprise billing, including benchmark payments and arbitration models.

Client expense: $1,460,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1781 - Payment Commission Data Act of 2019: Issues regarding providing the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to drug pricing and rebate data. H.R. 938 - Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019: Issues regarding discouraging parking of 180-day exclusivity by a first generic applicant that is blocking the approval of other generics. H.R. 1520 - Purple Book Continuity Act of 2019: Issues regarding codifying publication of the patents of approved biological products in the Purple Book in a similar format and with similar requirements to the Orange Book; Publication and regular updating of the Purple Book electronically on the FDAs website. H.R. 1503 - Orange Book Transparency Act of 2019: Issues regarding ensuring that the Orange Book is accurate and up-to-date, by requiring manufacturers to share complete and timely information with FDA, as well as ensuring that patents listed in the Orange Book are relevant to the approved drug product. H.R. 1499 - Protecting Consumer Access to Generic Drugs Act of 2019: Issues regarding brand-name and generic drug manufacturers entering into agreements in which the brand-name drug manufacturer pays the generic manufacturer to keep a generic equivalent off the market. H.R. 965, S. 340 - Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019: Issues regarding processes by which generic manufacturers can obtain sufficient quantities of brand drug samples for testing. H.R. 1385 - State Allowance for a Variety of Exchanges (SAVE) Act: Issues regarding federal funds to establish state-based Marketplaces. H.R. 1386 - Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act: Issues regarding funding for Federally-Facilitated Marketplace navigator program; requirements for navigator entities in each state; Health and Human Services ensuring that navigator grants are awarded to entities with demonstrated capacity to carry out the duties specified in the Affordable Care Act. H.R. 987 - Marketing and Outreach Restoration to Empower (MORE) Health Education Act of 2019: Issues related to restoring outreach and enrollment funding to assist consumers in signing up for health care. H.R. 1010 - Issues regarding Short-Term, Limited Duration Insurance. H.R. 986 - Protecting Americans with Preexisting Conditions Act of 2019: Issues regarding rescinding Section 1332 guidance of the ACA promulgated in October 2018. H.R. 1425 - State Health Care Premium Reduction Act: Issues regarding state reinsurance program and providing financial assistance to reduce out-of-pocket costs. H.R. 820 - Public Health Service Act: Issues regarding National Institutes of Health support to collect the medical specimens and information of children with selected cancers that have the least effective treatments. 657 - Drug Price Transparency (DPT) Act: Issues relating to drug and price transparency. S. 80, S. 172 - Issues regarding repeal and delay of the health insurer fee. Issues regarding surprise billing, including benchmark payments and arbitration models.

Client expense: $1,330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

S. 350, Competitive Health Insurance Reform Act (Daines) - McCarran-Ferguson Act S. 455, Marketing and Outreach Restoration to Empower Health Education Act (Shaheen) - funding for outreach and education on ACA Exchanges S. 466, Protecting Americans with Preexisting Conditions Act (Warner) - blocking updated Section 1332 guidance S. 560, Ensuring Lasting Smiles Act (Baldwin) - coverage mandate for treatment of congenital anomaly or birth defect S. 741, Cancer Drug Parity Act (Smith) -- cost sharing for oral anticancer drugs S. 913, Disclosure of Price Information to Enrollees (Braun) S. 961, Improving Health Insurance Affordability Act (Shaheen) - premium tax credits S. 964, Marketplace Certainty Act (Shaheen) - cost-sharing subsidies S. 967, Reducing Costs for Out-of-Network Services Act (Shaheen) - caps on out-of-network charges S. 981, Medicare-X Choice Act (Bennet) - public option S. 1033, CHOICE Act (Whitehouse) - public option S. 1125, Protect Act (Tillis) - pre-existing condition protections S. 1129, Medicare for All Act (Sanders) - government health insurance system S. 1170, Association Health Plans Act (Enzi) - codifying final rule for expanding AHPs S. 1266, Protecting Patients from Surprise Medical Bills Act (Scott) - surprise medical billing S. 1531, STOP Surprise Medical Bills Act (Cassidy-Bennet) - surprise medical billing S. 1576, Behavioral Health Coverage Transparency Act (Warren) - mental health parity S. 1577, Know the Price Act (Cassidy-Bennet) - restrictions on provider contracts S. 1737, Mental Health Parity Compliance Act (Murphy) - mental health parity S. 1948, Chronic Disease Management Act (Thune) - pre-deductible coverage of chronic disease prevention services S. 2546, Safe Step Act (Murkowski)-Step therapy exceptions H.R. 692, Pre-existing Conditions Protection Act (Walden) - pre-existing condition protections H.R. 986, Protecting Americans with Preexisting Conditions Act (Kuster) - blocking updated Section 1332 guidance H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act (Blunt Rochester) - funding for outreach and education on ACA Exchanges, Navigator program, and establishment of state-based Health Insurance Exchanges; drug pricing proposals H.R. 1010, Short-Term Plans (Castor) - blocking final rule that expands short-term plans H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act (Eshoo) - standardized disclosures for short-term plans H.R. 1379, Ensuring Lasting Smiles Act (Peterson) - coverage mandate for treatment of congenital anomaly or birth defect H.R. 1384, Medicare for All Act (Jayapal) - government health insurance system H.R. 1385, State Allowance for a Variety of Exchanges Act (Kim) - funding for establishment of state-based Health Insurance Exchanges H.R. 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act (Castor) - funding for Navigator Program H.R. 1418, Competitive Health Insurance Reform Act (DeFazio) - McCarran-Ferguson Act H.R. 1425, State Health Care Premium Reduction Act (Craig) - funding for state reinsurance programs H.R. 1510, Premium Relief Act (Burgess) -- Patient and State Stability Fund H.R. 1730, Cancer Drug Parity Act (Higgins) -- cost sharing for oral anticancer drugs H.R. 1884, Protecting Pre-Existing Conditions and Making Health Care More Affordable Act (Pallone) - reinsurance funding, stabilization and affordability proposals H.R. 2000, Medicare-X Choice Act (Delgado) - public option H.R. 2061, Pathway to Universal Coverage Act (Bera) - auto-enrollment H.R. 2085, CHOICE Act (Schakowsky) - public option H.R. 2183, State Flexibility and Patient Choice Act (Marshall) - flexibility in state innovation waivers H.R. 2848, Parity Enforcement Act (Norcross) - mental health parity H.R. 2874, Behavioral Health Coverage Transparency Act (Kennedy) - mental health parity H.R. 3165, Mental Health Parity Compliance Act (Porter) - mental health parity H.R. 3502, Protecting People From Surprise Medical Bills Act (Ruiz) - surprise medical billing H.R. 3630, No Surprises Act (Pallone)-surprise medical billing H.R. 3784, Air Ambulance Affordability Act of 2019 (Neguse)- air ambulances H.R. 4223, Protecting Patients from Surprise Medical Bills Act (Spano)-surprise medical billing H.R. 4379, Under Performing Directories that Affect Treating Emergencies Act (Axne)-provider directories H.R. 4457, Chronic Condition Copay Elimination Act (Underwood)- Eliminating copays for services/drugs for chronic conditions H.R. 4484, Flexibility Through Lower Expenses Health Care Act (Budd)-STLDI plans H.R. 4530, Native American Health Savings Improvement Act (Moolenaar)-HSAs H.R. 4575, Improving Provider Directories Act (Schrier)-provider directories H.R. 5010, State-Based Universal Health Care Act of 2019 (Khanna) - universal health care systems H.R. 5121, Healthcare Cost Transparency Act (Beyer) - provider price comparison tool H.R. 5144, Insurance Accountability and Transparency Act (Davids) - insurance have publicly accessible self-audit information H.R. 5239 Prescription Drug Price Reporting Act (Joyce) - reporting on drug expenditures and price changes under group health plans H. Res. 271 (Allred) - resolution urging DOJ to reverse position in Texas v. United States litigation Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

Client expense: $2,340,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; H.R.965 CREATES Act of 2019 H.R.986 Protecting Americans with Preexisting Conditions Act of 2019 H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1010 To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.1385 SAVE Act H.R.1386 ENROLL Act of 2019 H.R.1425 State Health Care Premium Reduction Act H.R.1499 Protecting Consumer Access to Generic Drugs Act of 2019 H.R.1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 H.R.2508 Better Respiration through Expanding Access to Tele-Health Act H.R.2839 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2020 H.R.2862 VACCINES Act of 2019 H.R.3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; S.2580, Department of the Interior, Environment, and Related Agencies Appropriations Act H.R.3630 No Surprises Act H.R.4622 Family Asthma Act S.340 CREATES Act of 2019 S.466 Protecting Americans with Pre-existing Conditions Act of 2019 S.946 Henrietta Lacks Enhancing Cancer Research Act of 2019 S.1125 Protect Act S.1895 Lower Health Care Costs Act S.1944 Public Health Funding Restoration Act. HR 3 Elijah E. Cummings Lower Drug Costs Now Act; H.R.4716 I CAN Act; HR 5230 Elijah E. Cummings Family Asthma Act

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Further Consolidated Appropriations Act, 2020 (H.R.1865) Dependent Income Exclusion Act pf 2019 (H.R.4417/S.2497) Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R.1143) ENROLL Act of 2019 (H.R.1386/S.1905) Family Coverage Act (S.1935) Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R.4768) Lower Health Care Costs Act (S.1895) Marketing & Outreach Restoration to Empower Health Education Act (MORE) (H.R.987) No Surprises Act (H.R.3630) Personal Health Investment Today Act (PHIT) (S.680/H.R.1679) Physical Activity Recommendations (PAR) for Americans Act (S.1608/H.R.2891) Pre-existing Conditions Protection Act of 2019 (H.R.692) Protect Act (S.1125) Protecting Americans with Pre-existing Conditions Act of 2019 (H.R.986) Public Health Funding Restoration Act (S.1944/H.R.3447) A Resolution Supporting the Designation of April 2019 as "National Donate Life Month"(H.Res 315/S.Res 162) South Asian Heart Health Awareness and Research Act of 2019 (H.R.3131) State Allowance for a Variety of Exchanges Act (SAVE Act) (H.R.1385) States Achieve Medicaid Expansion (S.585) State Health Care Premium Reduction Act (H.R.1425) Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (S.1531) To provide that the rule "STLDI" shall have no force or effect (H.R.1010) 911 Saves Act (H.R.1629) Implementation of: Menu Labeling Physical Activity Guidelines Recommendations Prevention and public Health Fund (PL 111-148, Sec 4002)

Client expense: $160,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Health Reimbursement Arrangements (HRAs)Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Consumer-facing app disclosures; Provider directories; Medicare for All; Medicare Buy-in; Maternal health; Senior's health care; Social determinants of health; Community health; Lyme disease; Cybersecurity, NBPP (Notice Benefit and Payment Parameters) H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48) H.R.2003 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) H.R.2004 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) S.973 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) S.971 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act 116th Congress (2019-2020) Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019) H.R.1010 - 116th Congress (2019-2020) To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) H.R.1520 - 116th Congress (2019-2020) Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] H.R.1897 - 116th Congress (2019-2020) MOMMA's Act Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 03/27/2019) H.R.1551 - 116th Congress (2019-2020) Quality Care for Moms and Babies Act Sponsor: Rep. Engel, Eliot L. [D-NY-16] (Introduced 03/06/2019 H.R.2902 - 116th Congress (2019-2020) Maternal CARE Act Sponsor: Rep. Adams, Alma S. [D-NC-12] H.R.2602 - 116th Congress (2019-2020) Healthy MOMMIES Act Sponsor: Rep. Pressley, Ayanna [D-MA-7] H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] H.R.2328 - 116th Congress (2019-2020) Community Health Investment, Modernization, and Excellence Act of 2019 Sponsor: Rep. O'Halleran, Tom [D-AZ-1] H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] H.R.360 - 116th Congress (2019-2020) Cyber Sense Act of 2019 Sponsor: Rep. Latta, Robert E. [R-OH-5] S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] S. 2897 - 116th Congress (2019-2020) Patient-Centered Outcomes Research Institute Reauthorization Act Sponsor: Sen. Mark Warner (D-VA) S. 2546 - 116th Congress (2019-2020) Safe Step Act Sen. Lisa Murkowski (R-AK) S. 2004 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Rep. Elijah Cummings (D-MD-07) H.R. 2774 - 116th Congress (2019-2020) Primary Care Patient Protection Act of 2019 Rep. Brad Schneider (D-IL-10)

Client expense: $1,840,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Medicare Advantage, Health Insurance Tax and Cost-sharing reductions. Prescription Drug Pricing. ACA stabilization (re-insurance). S.1129 - Medicare for All Act of 2019 H.R.1384 - Medicare for All Act of 2019 - Medicare for all bill H.R.2452 - Medicare for America Act of 2019 - Medicare for all bill S.1895 - Lower Health Care Costs Act S.340 - CREATES Act of 2019 S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1416 - Affordable Prescriptions for Patients Act of 2019 S.1224 - Stop STALLING Act H.R.1520 - Purple Book Continuity Act of 2019 H.R.1503 - Orange Book Transparency Act of 2019 H.R.965 - CREATES Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1385 - SAVE Act H.R.2375 - Preserve Access to Affordable Generics and Biosimilars Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 1865 - Further Consolidated Appropriations Act, 2020

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in; Maternal health; Seniors health care; social determinants of health; Community health, Cybersecurity. H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - 116th Congress (2019-2020) Strengthening Health Care and Lowering Prescription Drug Costs Act Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) H.R.1520 - 116th Congress (2019-2020) Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019) H.R.2902 - 116th Congress (2019-2020) Maternal CARE Act Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019) H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019) H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] (Introduced 09/18/2019) H.R.2328 - 116th Congress (2019-2020) Community Health Investment, Modernization, and Excellence Act of 2019 Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Introduced 04/15/2019) H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019) H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] (Introduced 06/05/2019) H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] (Introduced 07/25/2019) H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019) S. 1895-116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 06/19/2019) S2897-116th Congress (2019-2020) Patient-Centered Outcomes Research Institute Reauthorization Act Sponsor: Sen. Warner, Mark (D-VA) (Introduced 11/19/2019)

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 3: A bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. HR 4070: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. HR 3796: A bill to amend the Internal Revenue Code of 1986 to provide that coverage under Medicare is permissible for purposes of contributions to health savings accounts. HR 861: A bill to amend title XVIII of the Social Security Act to prevent surprise billing practices, and for other purposes. HR 3276: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. HR 2113: A bill to a mend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes. H.R. 2447: A bill to fully repeal the Health Insurance Tax S. 80: A bill to fully repeal the Health Insurance Tax H.R. 2782: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. S. 1510: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. H.R.2564: This bill creates a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA)-a federal law that allows an individual to maintain health coverage following loss of coverage due to termination of employment or another qualifying event. H.R. 1682: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. H.R. 1384: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 1129: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 981: A bill to establish a public health plan. H.R. 1346: To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. S. 470: To amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare. S. 1895: A bill to lower health care costs by preventing surprise medical bills, reducing prescription drug prices, improving transparency in health care, investing in public health and improving health information exchange. H.R. 3630: To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. HR 1682: A bill to amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. S 753: A bill to amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare. HR 748: A bill to amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. S 684: A bill to amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. HR 1884: A bill to amend the Patient Protection and Affordable Care Act to improve affordability of, undo sabotage with respect to, and increase access to health insurance coverage, and for other purposes. S 172: A bill to delay the reimposition of the annual fee on health insurance providers until after 2021. HR 1398: A bill to delay the reimposition of the annual fee on health insurance providers until after 2021. S 80: A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. HR 1385: A bill to amend the Patient Protection and Affordable Care Act to preserve the option of States to implement health care marketplaces, and for other purposes HR 1386: A bill to amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program, and for other purposes. HR 987: A bill to amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities. HR 986: A bill to provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. HR 100: A bill to provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect. HR 1425: A bill to amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market. HR 938: A bill to amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes HR 1520: A bill to amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes. HR 1503: A bill to amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes. HR (No Bill #) Payment Commission Data Act of 2019: A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR 1499: A bill prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes. HR 965: promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. H.R. 1158: An act making consolidated appropriations for the fiscal year ending September 30, 2020, and for other purposes. H.R. 1865: An act making consolidated appropriations for the fiscal year ending September 30, 2020, and for other purposes. H.R. 2477: A bill to amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. S. 1280: A bill to amend title XVIII of the Social Security Act to establish a system to notify individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes. H.R. 3708: A bill to amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts, and for other purposes. S. 2999: A bill to amend the Internal Revenue Code of 1986 to allow individuals with direct primary care service arrangements to remain eligible individuals for purposes of health savings accounts. H.R. 3: An act to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S. 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. H.R. 1277: A bill to establish a State public option through Medicaid to provide Americans with the choice of a high-quality, low-cost health insurance plan S. 489: A bill to establish a State public option through Medicaid to provide Americans with the choice of a high-quality, low-cost health insurance plan H.R. 2000: A bill to establish a public health plan H.R. 2452: A bill to amend the Social Security Act to establish a Medicare for America health program to provide for comprehensive health coverage for all Americans. H.R. 2463: A bill to provide for the establishment of Medicare part E public health plans, and for other purposes. H.R. 4527: A bill to amend title XVIII of the Social Security Act to provide an option for first responders age 50 to 64 who are separated from service due to retirement or disability to buy into Medicare. H.R. 2085: A bill to amend the Public Health Service Act to establish a public health insurance option, and for other purposes.

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; Transparency; Silverloading; Texas lawsuit; Surprise billing, Small Business; Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Provider directories; Medicare for All; Medicare Buy-in; Social determinants of health; NBPP (Notice Benefit and Payment Parameters); provider contracting, restrictions on steering and tiering H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act 116th Congress (2019-2020) Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019) H.R.1010 - 116th Congress (2019-2020) To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] S. 2897 - 116th Congress (2019-2020) Patient-Centered Outcomes Research Institute Reauthorization Act Sponsor: Sen. Mark Warner (D-VA) S. 2546 - 116th Congress (2019-2020) Safe Step Act Sen. Lisa Murkowski (R-AK)

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions H.R. 2279/S. 2546, Safe Step Act of 2019, regarding all bio-pharmaceutical related provisions

Client expense: $690,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Short Term Limited Duration Insurance (STLDI) Plans; Reinsurance; Cost Sharing Reductions (CSRs); Transparency; Silver Loading; Texas v. U.S. Lawsuit; Interoperability; Health Reimbursement Arrangements (HRAs); Surprise Billing; All Payer Claims Database; Negotiated Rate Disclosure; Provider Directories; Medicare for All; Medicare Buy-in; Outreach, Education, and Enrollment; Social Determinants of Health; 2021 Notice of Benefit and Payment Parameters (NBPP) HR 986 (116th Congress), Protecting Americans with Pre-existing Conditions Act of 2019, by Rep. Ann Kuster (D-NH). To provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. HR 987 (116th Congress), MORE Health Education Act, by Rep. Lisa Blunt Rochester (D-DE). To amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities. HR 1010 (116th Congress) by Rep. Kathy Castor (D-FL). To provide that the rule entitled Short-Term Limited Duration Insurance shall have no force or effect. HR 1143 (116th Congress), Educating Consumers on the Risks of Short-Term Plans Act of 2019, by Rep. Anna Eshoo (D-CA). To amend title XXVII of the Public Health Service Act to require a health insurance issuer offering short-term limited duration insurance to include a standardized disclosure and certain information with respect to coverage exclusions and premium variations in marketing, application, and enrollment materials distributed in connection with such insurance and prohibiting the sale of such insurance during certain periods. HR 1346 (116th Congress), Medicare Buy-In and Health Care Stabilization Act of 2019, by Rep. Brian Higgins (D-NY). To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. HR 1384 (116th Congress), Medicare for All Act of 2019, by Rep. Pramila Jayapal (D-WA). To establish an improved Medicare for All national health insurance program. HR 1385 (116th Congress), SAVE Act, by Rep. Andy Kim (D-NJ). To amend the Patient Protection and Affordable Care Act to preserve the option of States to implement health care marketplaces. HR 1386 (116th Congress), ENROLL Act of 2019, by Rep. Kathy Castor (D-FL). To amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program. HR 1425 (116th Congress), State Health Care Premium Reduction Act, by Rep. Angie Craig (D-MN). To amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market. HR 2274 (116th Congress), Primary Care Patient Protection Act of 2019, by Rep. Brad Schneider (D-IL). To amend the Internal Revenue Code of 1986 to require coverage without a deductible of certain primary care services by high deductible health plans. HR 2279 (116th Congress), Safe Step Act, by Rep. Raul Ruiz (D-CA). To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR 3502 (116th Congress), Protecting People from Surprise Medical Bills Act, by Rep. Raul Ruiz (D-CA). To amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes. HR 3630 (116th Congress), No Surprises Act, by Rep. Frank Pallone, Jr. (D-NJ). To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. HR 4004 (116th Congress), Social Determinants Accelerator Act of 2019, by Rep. Cheri Bustos (D-IL). To direct the Secretary of Health and Human Services to establish an interagency council on social determinants of health, and for other purposes. HR 4378 (116th Congress), Continuing Appropriations Act 2020, and Health Extenders Act of 2019, by Rep. Nita Lowey (D-NY). Making continuing appropriations for fiscal year 2020, and for other purposes. S 1895 (116th Congress), Lower Health Care Costs Act, by Sen. Lamar Alexander (R-TN). To lower health care costs.

Client expense: $490,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Treasury, Dept of, White House Office

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Alternatives to Opioids (ALTO) Demonstration program funding, Resident Physician Shortage Act of 2019 S. 348) - Increased funding for Medicare GME slots, Surprise Medical Bills (pending legislation), Medicaid DSH cuts, Improving Access to Medicare Coverage Act (H.R. 1682/S. 753) - Addressing the Medicare 3-Day Rule for nursing home care, Home Health Payment Innovation Act (S. 433) - Limit Medicare rate changes to 2 percent per year, Protecting Jessica Grubbs Legacy Act (S. 1012) - Federal privacy rules (42 CFR Part 2), Overdose Prevention and Patient Safety Act (H.R. 2062) - Federal privacy rules (42 CFR Part 2), Palliative Care and Hospice Education Act, Protecting Pre-Existing Conditions & Making Health Care More Affordable Act, State Allowance for a Variety of Exchanges (SAVE) Act (H.R. 1385), Pandemic All-Hazards legislation, Medicare area wage index

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the Childrens Health Insurance Program; Issues related to the President's Budget; H.R.965 CREATES Act of 2019 H.R.986 Protecting Americans with Preexisting Conditions Act of 2019 H.R.987 Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1010 To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. H.R.1385 SAVE Act H.R.1386 ENROLL Act of 2019 H.R.1425 State Health Care Premium Reduction Act H.R.1499 Protecting Consumer Access to Generic Drugs Act of 2019 H.R.1884 Protecting Pre-Existing Conditions and Making Health Care More Affordable Act of 2019 H.R.2508 Better Respiration through Expanding Access to Tele-Health Act H.R.2839 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2020 H.R.2862 VACCINES Act of 2019 H.R.3055 Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; S.2580, Department of the Interior, Environment, and Related Agencies Appropriations Act H.R.3630 No Surprises Act H.R.4622 Family Asthma Act H.RES.76 Expressing support for the designation of a "Women's Health Research Day". H.RES.315 Expressing support for the designation of April 2019 as "National Donate Life Month". S.340 CREATES Act of 2019 S.466 Protecting Americans with Pre-existing Conditions Act of 2019 S.946 Henrietta Lacks Enhancing Cancer Research Act of 2019 S.1125 Protect Act S.1895 Lower Health Care Costs Act S.1944 Public Health Funding Restoration Act S.RES.29 A resolution expressing support for the designation of a "Women's Health Research Day". S.RES.162 A resolution supporting the designation of April 2019 as "National Donate Life Month".

Client expense: $50,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE

S. 350, Competitive Health Insurance Reform Act (Daines) - McCarran-Ferguson Act S. 455, Marketing and Outreach Restoration to Empower Health Education Act (Shaheen) - funding for outreach and education on ACA Exchanges S. 466, Protecting Americans with Preexisting Conditions Act (Warner) - blocking updated Section 1332 guidance S. 560, Ensuring Lasting Smiles Act (Baldwin) - coverage mandate for treatment of congenital anomaly or birth defect S. 741, Cancer Drug Parity Act (Smith) -- cost sharing for oral anticancer drugs S. 913, Disclosure of Price Information to Enrollees (Braun) S. 961, Improving Health Insurance Affordability Act (Shaheen) - premium tax credits S. 964, Marketplace Certainty Act (Shaheen) - cost-sharing subsidies S. 967, Reducing Costs for Out-of-Network Services Act (Shaheen) - caps on out-of-network charges S. 981, Medicare-X Choice Act (Bennet) - public option S. 1033, CHOICE Act (Whitehouse) - public option S. 1125, Protect Act (Tillis) - pre-existing condition protections S. 1129, Medicare for All Act (Sanders) - government health insurance system S. 1170, Association Health Plans Act (Enzi) - codifying final rule for expanding AHPs S. 1266, Protecting Patients from Surprise Medical Bills Act (Scott) - surprise medical billing S. 1531, STOP Surprise Medical Bills Act (Cassidy-Bennet) - surprise medical billing S. 1576, Behavioral Health Coverage Transparency Act (Warren) - mental health parity S. 1577, Know the Price Act (Cassidy-Bennet) - restrictions on provider contracts S. 1737, Mental Health Parity Compliance Act (Murphy) - mental health parity S. 1948, Chronic Disease Management Act (Thune) - pre-deductible coverage of chronic disease prevention services S. 2546, Safe Step Act (Murkowski)-Step therapy exceptions H.R. 692, Pre-existing Conditions Protection Act (Walden) - pre-existing condition protections H.R. 986, Protecting Americans with Preexisting Conditions Act (Kuster) - blocking updated Section 1332 guidance H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act (Blunt Rochester) - funding for outreach and education on ACA Exchanges, Navigator program, and establishment of state-based Health Insurance Exchanges; drug pricing proposals H.R. 1010, Short-Term Plans (Castor) - blocking final rule that expands short-term plans H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act (Eshoo) - standardized disclosures for short-term plans H.R. 1379, Ensuring Lasting Smiles Act (Peterson) - coverage mandate for treatment of congenital anomaly or birth defect H.R. 1384, Medicare for All Act (Jayapal) - government health insurance system H.R. 1385, State Allowance for a Variety of Exchanges Act (Kim) - funding for establishment of state-based Health Insurance Exchanges H.R. 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act (Castor) - funding for Navigator Program H.R. 1418, Competitive Health Insurance Reform Act (DeFazio) - McCarran-Ferguson Act H.R. 1425, State Health Care Premium Reduction Act (Craig) - funding for state reinsurance programs H.R. 1510, Premium Relief Act (Burgess) -- Patient and State Stability Fund H.R. 1730, Cancer Drug Parity Act (Higgins) -- cost sharing for oral anticancer drugs H.R. 1884, Protecting Pre-Existing Conditions and Making Health Care More Affordable Act (Pallone) - reinsurance funding, stabilization and affordability proposals H.R. 2000, Medicare-X Choice Act (Delgado) - public option H.R. 2061, Pathway to Universal Coverage Act (Bera) - auto-enrollment H.R. 2085, CHOICE Act (Schakowsky) - public option H.R. 2183, State Flexibility and Patient Choice Act (Marshall) - flexibility in state innovation waivers H.R. 2848, Parity Enforcement Act (Norcross) - mental health parity H.R. 2874, Behavioral Health Coverage Transparency Act (Kennedy) - mental health parity H.R. 3165, Mental Health Parity Compliance Act (Porter) - mental health parity H.R. 3502, Protecting People From Surprise Medical Bills Act (Ruiz) - surprise medical billing Discussion Draft, No Surprises Act (Pallone-Walden) - surprise medical billing H.R. 3630, No Surprises Act (Pallone)-surprise medical billing H.R. 3784, Air Ambulance Affordability Act of 2019 (Neguse)- air ambulances H.R. 4223, Protecting Patients from Surprise Medical Bills Act (Spano)-surprise medical billing H.R. 4379, Under Performing Directories that Affect Treating Emergencies Act (Axne)-provider directories H.R. 4457, Chronic Condition Copay Elimination Act (Underwood)- Eliminating copays for services/drugs for chronic conditions H.R. 4484, Flexibility Through Lower Expenses Health Care Act (Budd)-STLDI plans H.R. 4530, Native American Health Savings Improvement Act (Moolenaar)-HSAs H.R. 4575, Improving Provider Directories Act (Schrier)-provider directories H. Res. 271 (Allred) - resolution urging DOJ to reverse position in Texas v. United States litigation Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; pre-existing condition insurance plans; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

Client expense: $2,110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, White House Office

Dependent Income Exclusion Act pf 2019 (H.R.4417/S.2497) Educating Consumers on the Risks of Short-Term Plans Act of 2019 (H.R.1143) ENROLL Act of 2019 (H.R.1386/S.1905) Family Coverage Act (S.1935) State Health Care Premium Reduction Act (H.R.1425) A resolution supporting the designation of April 2019 as "National Donate Life Month"(H.Res 315/S.Res 162) Lower Health Care Costs Act (S.1895) Marketing & Outreach Restoration to Empower Health Education Act (MORE) (H.R.987) No Surprises Act (H.R.3630) Personal Health Investment Today Act (PHIT) (S.680/H.R.1679) Physical Activity Recommendations (PAR) for Americans Act (S.1608/H.R.2891) Pre-existing Conditions Protection Act of 2019 (H.R.692) Protect Act (S.1125) Protecting Americans with Pre-existing Conditions Act of 2019 (H.R.986) Public Health Funding Restoration Act (S.1944/H.R.3447) South Asian Heart Health Awareness and Research Act of 2019 (H.R.3131) State Allowance for a Variety of Exchanges Act (SAVE Act) (H.R.1385) States Achieve Medicaid Expansion (S.585) Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 (S.1531) To provide that the rule "STLDI" shall have no force or effect (H.R.1010) 911 Saves Act (H.R.1629) Implementation of: Menu Labeling Physical Activity Guidelines Recommendations Prevention and public Health Fund (PL 111-148, Sec 4002)

Client expense: $33,764 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs), Outreach, Education, and Enrollment; Prior Authorization; All-payer claims database; Negotiated rate disclosure; Consumer-facing app disclosure; Medicare for All; Medicare Buy-in. H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) H.R.2003 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) H.R.2004 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) S.971 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - 116th Congress (2019-2020) Strengthening Health Care and Lowering Prescription Drug Costs Act Sponsor: Rep. Blunt Rochester, Lisa [D-DE- At Large] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) H.R.1520 - 116th Congress (2019-2020) Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] (Introduced 02/07/2019) H.R.1897 - 116th Congress (2019-2020) MOMMA's Act Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 03/27/2019) H.R.1551 - 116th Congress (2019-2020) Quality Care for Moms and Babies Act Sponsor: Rep. Engel, Eliot L. [D-NY-16] (Introduced 03/06/2019) H.R.2902 - 116th Congress (2019-2020) Maternal CARE Act Sponsor: Rep. Adams, Alma S. [D-NC-12] (Introduced 05/22/2019) H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] (Introduced 07/09/2019) H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] (Introduced 09/18/2019) H.R.2328 - 116th Congress (2019-2020) Community Health Investment, Modernization, and Excellence Act of 2019 Sponsor: Rep. O'Halleran, Tom [D-AZ-1] (Introduced 04/15/2019) H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] (Introduced 06/24/2019) H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] (Introduced 06/05/2019) H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] (Introduced 07/25/2019) H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 04/10/2019)

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Advantage, Health Insurance Tax and Cost-sharing reductions. Prescription Drug Pricing. ACA stabilization (re-insurance). S.1129 - Medicare for All Act of 2019 H.R.1384 - Medicare for All Act of 2019 - Medicare for all bill H.R.2452 - Medicare for America Act of 2019 - Medicare for all bill S.1895 - Lower Health Care Costs Act S.340 - CREATES Act of 2019 S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1416 - Affordable Prescriptions for Patients Act of 2019 S.1224 - Stop STALLING Act H.R.1520 - Purple Book Continuity Act of 2019 H.R.1503 - Orange Book Transparency Act of 2019 H.R.965 - CREATES Act of 2019 H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act H.R.1385 - SAVE Act H.R.2375 - Preserve Access to Affordable Generics and Biosimilars Act H.R.3 - Lower Drug Costs Now Act of 20191. S.2543 - Prescription Drug Pricing Reduction Act of 2019

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Reinsurance; CSRs; 42 CFR Part 2; Transparency; Silverloading; Texas lawsuit; Surprise billing, Transparency, Biosimilars; Provider Directories; Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Medicare for All; Medicare Buy-in; Social determinants of health; provider contracting H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act 116th Congress (2019-2020) Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019) H.R.1010 - 116th Congress (2019-2020) To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36]

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Texas lawsuit; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs)Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Consumer-facing app disclosures; Provider directories; Medicare for All; Medicare Buy-in; Maternal health; Senior's health care; Social determinants of health; Community health; Lyme disease; Cybersecurity H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48) H.R.2003 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) H.R.2004 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) S.973 - 116th Congress (2019-2020) Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) S.971 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.1386 - 116th Congress (2019-2020) ENROLL Act of 2019 Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019) H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act 116th Congress (2019-2020) Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019) H.R.1010 - 116th Congress (2019-2020) To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) H.R.1520 - 116th Congress (2019-2020) Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] H.R.1897 - 116th Congress (2019-2020) MOMMA's Act Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 03/27/2019) H.R.1551 - 116th Congress (2019-2020) Quality Care for Moms and Babies Act Sponsor: Rep. Engel, Eliot L. [D-NY-16] (Introduced 03/06/2019 H.R.2902 - 116th Congress (2019-2020) Maternal CARE Act Sponsor: Rep. Adams, Alma S. [D-NC-12] H.R.2602 - 116th Congress (2019-2020) Healthy MOMMIES Act Sponsor: Rep. Pressley, Ayanna [D-MA-7] H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] H.R.2328 - 116th Congress (2019-2020) Community Health Investment, Modernization, and Excellence Act of 2019 Sponsor: Rep. O'Halleran, Tom [D-AZ-1] H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] H.R.360 - 116th Congress (2019-2020) Cyber Sense Act of 2019 Sponsor: Rep. Latta, Robert E. [R-OH-5] S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN]

Client expense: $1,530,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

HR 3: A bill to establish a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees, and for other purposes. S 2543: A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes. HR 4070: A bill to streamline the employer reporting process and strengthen the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy. HR 3796: A bill to amend the Internal Revenue Code of 1986 to provide that coverage under Medicare is permissible for purposes of contributions to health savings accounts. HR 861: A bill to amend title XVIII of the Social Security Act to prevent surprise billing practices, and for other purposes. HR 3276: A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes. HR 2113: A bill to a mend titles XI and XVIII of the Social Security Act to provide for drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, and for other purposes. H.R. 2447: A bill to fully repeal the Health Insurance Tax S. 80: A bill to fully repeal the Health Insurance Tax H.R. 2782: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. S. 1510: This bill increases the hours of service required for an employee to be classified as a full-time employee for purposes of the employer mandate under the Patient Protection and Affordable Care Act to provide minimum essential health care coverage to full-time employees. The bill increases the hours of service threshold from an average of at least 30 hours of service a week to an average of at least 40 hours of service a week. H.R.2564: This bill creates a special Medicare enrollment period for individuals enrolled in, or transitioning out of, continuation coverage under the Consolidated Omnibus Budget Reconciliation Act (COBRA)-a federal law that allows an individual to maintain health coverage following loss of coverage due to termination of employment or another qualifying event. H.R. 1682: This bill deems an individual receiving outpatient observation services in a hospital as an inpatient for purposes of satisfying the three-day inpatient hospital-stay requirement with respect to Medicare coverage of skilled nursing facility services. H.R. 1384: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 1129: This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). S. 981: A bill to establish a public health plan. H.R. 1346: To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. S. 470: To amend title XVIII of the Social Security Act to provide for an option for any citizen or permanent resident of the United States age 50 to 64 to buy into Medicare. S. 1895: A bill to lower health care costs by preventing surprise medical bills, reducing prescription drug prices, improving transparency in health care, investing in public health and improving health information exchange. H.R. 3630: To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. HR 1682: A bill to amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. S 753: A bill to amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare. HR 748: A bill to amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. S 684: A bill to amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. HR 1884: A bill to amend the Patient Protection and Affordable Care Act to improve affordability of, undo sabotage with respect to, and increase access to health insurance coverage, and for other purposes. S 172: A bill to delay the reimposition of the annual fee on health insurance providers until after 2021. HR 1398: A bill to delay the reimposition of the annual fee on health insurance providers until after 2021. S 80: A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. HR 1385: A bill to amend the Patient Protection and Affordable Care Act to preserve the option of States to implement health care marketplaces, and for other purposes HR 1386: A bill to amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program, and for other purposes. HR 987: A bill to amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities. HR 986: A bill to provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. HR 100: A bill to provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect. HR 1425: A bill to amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market. HR 938: A bill to amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes HR 1520: A bill to amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes. HR 1503: A bill to amend the Federal Food, Drug, and Cosmetic Act regarding the list under section 505(j)(7) of the Federal Food, Drug, and Cosmetic Act, and for other purposes. HR (No Bill #) Payment Commission Data Act of 2019: A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information. HR 1499: A bill prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes. HR 965: promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 985, Fair Access for Safe and Timely (FAST) Generics Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 986, Protecting American with Preexisting Conditions Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 1010, Short-Term, Limited Duration Insurance (STLDI), regarding all bio-pharmaceutical related provisions. H.R. 1323, Rural Hospital Frontier Fairness Act, regarding all bio-pharmaceutical related provisions. H.R. 1385, State Allowance for a Variety of Exchanges (SAVE) Act, regarding all bio-pharmaceutical related provisions. H.R. 1386, Expanded Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act, regarding all bio-pharmaceutical related provisions. H.R. 1409, Transparency in All Health Care Pricing Act, regarding all bio-pharmaceutical related provisions. H.R. 1425, State Health Care Premium Reduction Act, regarding all bio-pharmaceutical related provisions. H.R. 1478, Insulin importation, regarding all bio-pharmaceutical related provisions. H.R. 1503, Orange Book Transparency Act, regarding all bio-pharmaceutical related provisions. H.R. 1506, Fair and Immediate Release (FAIR) of Generics Act, regarding all bio-pharmaceutical related provisions. H.R. 1520, Purple Book Continuity Act, regarding all bio-pharmaceutical related provisions. H.R. 2011, Protecting Access to Biosimilars Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2038, State-based , Market-Oriented, Prescription Drug Negotiations Act of 2019, regarding all bio-pharmaceutical related provisions. H.R. 2064, Product Sample reporting, regarding all bio-pharmaceutical related provisions. S. 61, Safe and Affordable Drugs from Canada Act, regarding all bio-pharmaceutical related provisions. S. 97, Affordable and Safe Drug Importation Act, regarding all bio-pharmaceutical related provisions. S. 102, Prescription Drug Price Relief Act, regarding all bio-pharmaceutical related provisions. S. 344/H.R. 990, Hatch-Waxman Integrity Act, regarding all bio-pharmaceutical related provisions. S. 366/H.R. 1188, FLAT Prices Act- Reduced exclusivity period for certain price hikes, regarding all bio-pharmaceutical related provisions. S. 418, FDA Accountability for Public Safety Act, regarding all bio-pharmaceutical related provisions. S. 419, Protecting Americans from Dangerous Opioids Act, regarding all bio-pharmaceutical related provisions. S. 637, CURE High Drug Prices Act, regarding all bio-pharmaceutical related provisions. S. 657, Drug Price Transparency Act, regarding all bio-pharmaceutical related provisions. S. 658, Accelerated Drug Approval for Prescription Therapies Act, regarding all bio-pharmaceutical related provisions. S. 659, Biologic Patent Transparency Act, regarding all bio-pharmaceutical related provisions. S. 660, Transparency in Petitions Act, regarding all bio-pharmaceutical related provisions. S. 709, Establishes public dashboard for price and utilization of drugs purchased by federal programs, regarding all bio-pharmaceutical related provisions. S. 741 /H.R. 1730, Cancer Drug Parity Act, regarding all bio-pharmaceutical related provisions. S. 844, Short Competition Act, regarding all bio-pharmaceutical related provisions. S. 977, Transparent Drug Pricing Act of 2019, regarding all bio-pharmaceutical related provisions. S. 989, STEER Act, regarding all bio-pharmaceutical related provisions. S. 1140, A bill to amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biological product license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009, regarding all bio-pharmaceutical related provisions. S.1169, FDA citizen petition, regarding all bio-pharmaceutical related provisions. S. 1209, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to approval of abbreviated new drug applications, regarding all bio-pharmaceutical related provisions. H.R. 2115, Public Disclosure of Drug Discounts Act, regarding all bio-pharmaceutical related provisions H.R.2296/S.1391, FAIR Drug Pricing Act, regarding all bio-pharmaceutical related provisions H.R.2700, Lowering Prescription Drug Costs and Extending Community Health Centers and other Health Priorities Act, regarding all bio-pharmaceutical related provisions H.R. 3223, Pharmacy Benefit Manager Accountability Study Act, regarding all bio-pharmaceutical related provisions S. 1361/H.R.2584, Preventive Health Savings Act, regarding all bio-pharmaceutical related provisions S. 1437, DTC Act, regarding all bio-pharmaceutical related provisions S.1532, Pharmacy Benefit Managers Accountability Study Act, regarding all bio-pharmaceutical related provisions S.1636, Ensuring Innovation Act, regarding all bio-pharmaceutical related provisions S. 1664, Prescription Drug Price Reporting Act, regarding all bio-pharmaceutical related provisions S. 1801, Affordable Medications Act, regarding all bio-pharmaceutical related provisions S. 1895, Lowering Health Costs Act, regarding all bio-pharmaceutical related provisions S. 1897, a bill to establish a process for updating the labeling of certain drugs with outdated labeling, regarding all bio-pharmaceutical related provisions S. 1897/H.R. 3523, End Price Gouging for Medications Act, regarding all bio-pharmaceutical related provisions S. 2004, Emergency Access to Insulin Act, regarding all bio-pharmaceutical related provisions

Client expense: $1,240,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, U.S. Trade Representative (USTR)

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Risk Adjustment; State Flexibility; Marketplace Stability; Individual Market Reform; Section 1332 Waivers; Short Term Limited Duration Insurance (STLDI); Association Health Plans (AHPs); Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; Cost Sharing Reductions (CSRs); Transparency; Silver Loading; Texas v. U.S. Lawsuit; Interoperability; Health Reimbursement Arrangements (HRAs); Surprise Billing; Provider Directories; All Payer Claims Database; Medicare for All; Medicare Buy-in; Outreach, Education, and Enrollment; Social Determinants of Health HR 986 (116th Congress), Protecting Americans with Pre-existing Conditions Act of 2019, by Rep. Ann Kuster (D-NH). To provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. HR 987 (116th Congress), MORE Health Education Act, by Rep. Lisa Blunt Rochester (D-DE). To amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities. HR 1010 (116th Congress) by Rep. Kathy Castor (D-FL). To provide that the rule entitled Short-Term Limited Duration Insurance shall have no force or effect. HR 1143 (116th Congress), Educating Consumers on the Risks of Short-Term Plans Act of 2019, by Rep. Anna Eshoo (D-CA). To amend title XXVII of the Public Health Service Act to require a health insurance issuer offering short-term limited duration insurance to include a standardized disclosure and certain information with respect to coverage exclusions and premium variations in marketing, application, and enrollment materials distributed in connection with such insurance and prohibiting the sale of such insurance during certain periods. HR 1346 (116th Congress), Medicare Buy-In and Health Care Stabilization Act of 2019, by Rep. Brian Higgins (D-NY). To amend title XVIII of the Social Security Act to provide for an option for individuals who are ages 50 to 64 to buy into Medicare, to provide for health insurance market stabilization, and for other purposes. HR 1384 (116th Congress), Medicare for All Act of 2019, by Rep. Pramila Jayapal (D-WA). To establish an improved Medicare for All national health insurance program. HR 1385 (116th Congress), SAVE Act, by Rep. Andy Kim (D-NJ). To amend the Patient Protection and Affordable Care Act to preserve the option of States to implement health care marketplaces. HR 1386 (116th Congress), ENROLL Act of 2019, by Rep. Kathy Castor (D-FL). To amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program. HR 1425 (116th Congress), State Health Care Premium Reduction Act, by Rep. Angie Craig (D-MN). To amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market. HR 2279 (116th Congress), Safe Step Act, by Rep. Raul Ruiz (D-CA). To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide an exceptions process for any medication step therapy protocol, and for other purposes. HR 3502 (116th Congress), Protecting People From Surprise Medical Bills Act, by Rep. Raul Ruiz (D-CA). To amend the Public Health Service Act and title XI of the Social Security Act to protect health care consumers from surprise billing practices, and for other purposes. HR 3630 (116th Congress), No Surprises Act, by Rep. Frank Pallone, Jr. (D-NJ). To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. HR 4004 (116th Congress), Social Determinants Accelerator Act of 2019, by Rep. Cheri Bustos (D-IL). To direct the Secretary of Health and Human Services to establish an interagency council on social determinants of health, and for other purposes. HR 4378 (116th Congress), Continuing Appropriations Act 2020, and Health Extenders Act of 2019, by Rep. Nita Lowey (D-NY). Making continuing appropriations for fiscal year 2020, and for other purposes. S 1895 (116th Congress), Lower Health Care Costs Act, by Sen. Lamar Alexander (R-TN). To lower health care costs.

Client expense: $260,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Treasury, Dept of, White House Office

Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Point of Sale; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Surprise billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs)Outreach, Education, and Enrollment; Prior Authorization; All payer claims database; Negotiated rate disclosure; Provider directories; Medicare for All; Medicare Buy-in; Maternal health; Senior's health care; Social determinants of health; Community health; Lyme disease; Cybersecurity H.R.1346 - 116th Congress (2019-2020) Medicare Buy-In and Health Care Stabilization Act of 2019 Sponsor: Rep. Higgins, Brian [D-NY-26] (Introduced 02/25/2019) H.R.1384 - 116th Congress (2019-2020) Medicare for All Act of 2019 Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 02/27/2019) H.R.3502 - 116th Congress (2019-2020) Protecting People From Surprise Medical Bills Act Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 06/26/2019) Cosponsors: (48) H.R.2003 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019) S.971 - 116th Congress (2019-2020) Ensuring FEHBP Coverage During Shutdowns Act Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019) H.R.1385 - 116th Congress (2019-2020) SAVE Act Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019) H.R.987 - Strengthening Health Care and Lowering Prescription Drug Costs Act 116th Congress (2019-2020) Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019) H.R.1010 - 116th Congress (2019-2020) To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect. Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019) H.R.986 - 116th Congress (2019-2020) Protecting Americans with Preexisting Conditions Act of 2019 Sponsor: Rep. Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019) H.R.1425 - 116th Congress (2019-2020) State Health Care Premium Reduction Act Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019) H.R.1143 - 116th Congress (2019-2020) Educating Consumers on the Risks of Short-Term Plans Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019) H.R.1520 - 116th Congress (2019-2020) Purple Book Continuity Act of 2019 Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019) S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 06/19/2019) H.R.1046 - 116th Congress (2019-2020) Medicare Negotiation and Competitive Licensing Act of 2019 Sponsor: Rep. Doggett, Lloyd [D-TX-35] H.R.1897 - 116th Congress (2019-2020) MOMMA's Act Sponsor: Rep. Kelly, Robin L. [D-IL-2] (Introduced 03/27/2019) H.R.1551 - 116th Congress (2019-2020) Quality Care for Moms and Babies Act Sponsor: Rep. Engel, Eliot L. [D-NY-16] (Introduced 03/06/2019 H.R.2902 - 116th Congress (2019-2020) Maternal CARE Act Sponsor: Rep. Adams, Alma S. [D-NC-12] H.R.2602 - 116th Congress (2019-2020) Healthy MOMMIES Act Sponsor: Rep. Pressley, Ayanna [D-MA-7] H.R.3630 - 116th Congress (2019-2020) No Surprises Act Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6] H.R.4378 - 116th Congress (2019-2020) Continuing Appropriations Act, 2020, and Health Extenders Act of 2019 Sponsor: Rep. Lowey, Nita M. [D-NY-17] H.R.2328 - 116th Congress (2019-2020) Community Health Investment, Modernization, and Excellence Act of 2019 Sponsor: Rep. O'Halleran, Tom [D-AZ-1] H.R.3439 - 116th Congress (2019-2020) PATIENT Act Sponsor: Rep. Beyer, Donald S., Jr. [D-VA-8] H.R.3107 - 116th Congress (2019-2020) Improving Seniors' Timely Access to Care Act of 2019 Sponsor: Rep. DelBene, Suzan K. [D-WA-1] H.R.4004 - 116th Congress (2019-2020) Social Determinants Accelerator Act of 2019 Sponsor: Rep. Bustos, Cheri [D-IL-17] H.R.2279 - 116th Congress (2019-2020) Safe Step Act Sponsor: Rep. Ruiz, Raul [D-CA-36] H.R.360 - 116th Congress (2019-2020) Cyber Sense Act of 2019 Sponsor: Rep. Latta, Robert E. [R-OH-5] S.1895 - 116th Congress (2019-2020) Lower Health Care Costs Act Sponsor: Sen. Alexander, Lamar [R-TN]

Client expense: $97,200 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE